Results 81 to 90 of about 953,090 (297)

Interpreting the effects of DNA polymerase variants at the structural level

open access: yesMolecular Oncology, EarlyView.
Using MAVISp and molecular dynamics simulations, we analyzed over 60 000 missense variants in POLE and POLD1 from ClinVar, COSMIC, cBioPortal, and saturation mutagenesis. Identified mechanistic indicators, including stability, binding, and long‐range, enable structural interpretation, providing ACMG‐like evidence for possible reclassification of VUS ...
Matteo Arnaudi   +7 more
wiley   +1 more source

Space Medicine Lab May 1960 (11)

open access: yes, 1960
A close up view of tubing for experiments within a Space Medicine Lab, May ...

core  

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

open access: yesMolecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary   +1 more
wiley   +1 more source

Space Medicine Lab May 1960 (8)

open access: yes, 1960
A view of two rooms within a Space Medicine Lab, May ...

core  

Longitudinal genome‐wide aneuploidy measurements in circulating cell‐free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer

open access: yesMolecular Oncology, EarlyView.
Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi   +14 more
wiley   +1 more source

Space Medicine Lab May 1960 (1)

open access: yes, 1960
A view of one instrument within the Space Medicine Lab May ...

core  

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Space Medicine of the Next Decade as Viewed by a Physician and Physiologist

open access: yes, 1950
Presented at the Tenth Anniversary Commemoration of the Founding of the Department of Space Medicine, at the School of Aviation Medicine, USAF, Randolph Air Force ...
Strughold, Hubertus O.
core  

Benefits of Space Medicine Research for Healthcare on Earth. [PDF]

open access: yesCureus, 2023
Shirah B   +3 more
europepmc   +1 more source

[Space medicine].

open access: yesSrpski arhiv za celokupno lekarstvo, 2000
The National Academy of Sciences Committee on Space Biology and Medicine points out that space medicine is unique among space sciences, because in addition to addressing questions of fundamental scientific interest, it must address clinical or human ...
Pool, Sam L.
openaire   +3 more sources

Home - About - Disclaimer - Privacy